You can also learn more about determining if your current ADHD medication works and what you may discuss with your healthcare team about possible care plan changes. Both Guanfacine IR and Intuniv ...

Intuniv is only the second non-stimulant treatment for the condition, following Lilly's off-patent drug Strattera. Shire’s non-stimulant ADHD drug approved in Europe | pharmaphorum Skip to main ...

Attention-deficit hyperactivity disorder (ADHD) medications are prescribed to manage common ADHD symptoms, like difficulty focusing, impulsiveness, and hyperactivity. Medications approved to treat ...